| Status | Study |
| Not yet recruiting |
Study Name: A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia Condition: Aplastic Anemia Date: 2017-01-12 Interventions: Drug: Eltrombopag Tablet for o |
| Active, not recruiting |
Study Name: Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia Condition: Aplastic Anemia Date: 2016-05-09 Interventions: Biological: Romiplostim Weekly SC administration |
| Recruiting |
Study Name: The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia Condition: Severe Aplastic Anemia Date: 2016-04-07 Interventions: Procedure: IST ATG 3.5mg/kg/d |
| Recruiting |
Study Name: Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia Condition: Severe Aplastic Anemia Date: 2015-03-25 Interventions: Drug: Rabbit antithymoglobulin (ATG) |
| Recruiting |
Study Name: Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia Condition: Aplastic Anemia Date: 2014-01-02 Interventions: Drug: ATG-fresenius we will create 2 arms as per randomiza |
| Withdrawn |
Study Name: Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia Condition: Aplastic Anemia Date: 2013-11-21 Interventions: Drug: cyclophosphamide,cyclosporine A Drug,cyclophosphamid |
| Completed |
Study Name: Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients Condition: Aplastic Anemia Date: 2013-03-05 Interventions: Drug: ICL670A and standard immunosupressive therapy (Cyclosporine A) |
| Withdrawn |
Study Name: Alemtuzumab and Rituximab in Aplastic Anemia Condition: Aplastic Anemia Date: 2011-07-29 Interventions: Drug: Alemtuzumab and Rituximab |
| Recruiting |
Study Name: Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome Condition: Aplastic Anemia and Other Marrow Failure Syndrome Date: 2011-03-06 Interventions: Other: Database Database |
| Completed |
Study Name: Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia Condition: Aplastic Anemia Date: 2011-02-16 Interventions: Biological: Intravenous bone marrow mesenchymal stem cells infusion After standard immunosuppressive the |